glp-1 kidney stones Can GLP‑1 medications increase stone risk? A UAB urologist offers insight WCET 2025: The Impact of

We continue to model 2030 E[stimated] orforglipron sales of $13.5B, Risinger saida figure 35% above the $10 billion forecast offered by a consensus of analysts assembled through the Visible Alpha equities research platform

GLP-1 medications like Ozempic and Zepbound have been heralded for their unparalleled success in treating obesity and type 2 diabetes

Results last as long as you maintain your health and protect your skin

Onceweekly semaglutide in adults with overweight or obesity

Compounders must now pull their products

Transcriptional adaptation of Shigella flexneri during infection of macrophages and epithelial cells: insights into the strategies of a cytosolic bacterial pathogen